In the rapidly evolving field of synthetic biology, a groundbreaking study from the University of Warwick has unveiled a transformative approach to enhance the productivity of engineered microbial cell factories, as detailed in a recent publication in Nature Communications . These microscopic
In a groundbreaking move that has captured the attention of both the pharmaceutical industry and economic analysts, Eli Lilly and Co. has unveiled plans for a staggering $5 billion biomanufacturing facility in Goochland County, Virginia. Nestled in the West Creek Business Park, just a short
The pharmaceutical industry stands at a critical juncture, where the urgent need for faster, more sustainable, and patient-focused solutions is driving unprecedented change, as vividly demonstrated at the DCAT Summit held on June 4–5 in Lugano, Switzerland. Under the compelling theme "Expedition
In a striking move that underscores the growing emphasis on domestic manufacturing in the biopharmaceutical sector, Amgen, a titan in the American biotech landscape, has committed a substantial $650 million to expand its biologics facility in Juncos, Puerto Rico. This investment is not merely a
Lipid reprogramming has emerged as a critical frontier in understanding and treating clear cell renal cell carcinoma (ccRCC), the predominant subtype of kidney cancer that accounts for a significant portion of cases worldwide. This metabolic transformation, where tumor cells drastically alter how
The spinner flask market is emerging as a cornerstone of laboratory equipment, particularly within the realm of cell culture technologies, as it addresses the growing needs of biotechnology and pharmaceutical sectors. These specialized vessels, engineered to cultivate cell cultures under
